PSYCHEMEDICS CORP

PMDI

Explore Our Financial Data > Companies > PSYCHEMEDICS CORP

Identification

Click on a field for details on how to access that data via Web API, Excel, or CSV Download.

Ticker	PMDI
CIK	0000806517
SIC	8071
Sector	Services
Industry Category	Healthcare
Industry Group	Services – Health

Contact

Address	125 NAGOG PARK, ACTON, MA, 01720
Website	www.psychemedics.com
Phone	978-206-8220
CEO	Raymond C. Kubacki
Employees	140

Access This Data

Our team will help you customize a package that meets the needs of your business.

Request a Consultation

Standardized Financials

docs

Intrinio provides professional-grade historical financial data. This data is standardized, cleansed and verified to ensure the highest quality data sourced directly from the XBRL financial statements. The primary purpose of standardized financials are to facilitate comparability across a single company’s fundamentals and across all companies fundamentals.

For example, it is possible to compare total revenues between two companies as of a certain point in time, or within a single company across multiple time periods. This is not possible using the as reported financial statements because of the inherent complexity of reporting standards.

Below is a preview of several data points from each financial statement, as well as a sample of our many calculated metrics:

Income Statement

Revenue	$19.68 million
Pre-Tax Income	$-1.92 million
Net Income	$-1.86 million
Net Income to Common	$-1.86 million
EPS	N/A

View All

Balance Sheet

Cash	$1.42 million
Assets	$8.32 million
Liabilities	$3.19 million
Common Equity	$5.13 million
Liabilities & Equity	$8.32 million

View All

Cash Flow Statement

Net Income	$-1.86 million
Cash From Operating Activities	$929,000.00
Cash From Investing Activities	$-87,000.00
Cash From Financing Activities	$-1.39 million
Change in Cash	$-547,000.00

View All

Calculations

NOPAT	$-1.33 million
EBITDA	$165,000.00
Price to Earnings	N/A
Price to Book	$14,449.33
ROE	-31.54%

View All

Latest News

docs

Intrinio provides up-to-date news articles on every US company from various sources. Here are several examples:

US Penny Stocks To Watch In December 2024

As the S&P 500 and Nasdaq Composite reach record highs following positive jobs data, investor confidence in the U.S. economy remains robust. Penny stocks, often associated with smaller or newer companies, continue to offer intriguing opportunities for growth despite their historical reputation as a niche investment area. By identifying those with strong financial health and potential for expansion, investors can uncover hidden gems that might provide both stability and significant upside...

Article Link

Psychemedics Corporation Announces Reverse and Forward Stock Split

DALLAS, Dec. 02, 2024 (GLOBE NEWSWIRE) -- Psychemedics Corporation (Nasdaq: PMD) (the “Company”), the world’s leading provider of hair testing for drugs of abuse, today announced that, following the approval of the Company’s stockholders at its Annual Meeting of Stockholders held on November 25, 2024, the Company’s Board of Directors has approved a 1-for-5,000 reverse stock split of its common stock (the “Reverse Stock Split”) followed immediately by a 5,000-for-1 forward stock split of its comm

Article Link

Psychemedics Corporation Reminds Stockholders to Cast Their Votes for Upcoming Annual Meeting of Stockholders

DALLAS, Nov. 18, 2024 (GLOBE NEWSWIRE) -- Psychemedics Corporation (NASDAQ: PMD), a global leader in hair testing, reminds its stockholders to vote ahead of the Company’s upcoming annual meeting of stockholders scheduled for November 25, 2024. Each stockholder’s vote is important. The Company’s Board of Directors recommends that stockholders vote "FOR" each proposal at the annual meeting. Instructions for voting your shares are set forth below. The record date for the annual meeting is October 8

Article Link

Psychemedics Third Quarter 2024 Earnings: US$0.091 loss per share (vs US$0.36 loss in 3Q 2023)

Psychemedics ( NASDAQ:PMD ) Third Quarter 2024 Results Key Financial Results Revenue: US$5.18m (down 9.3% from 3Q...

Article Link

Psychemedics: Q3 Earnings Snapshot

DALLAS (AP) — Psychemedics Corp. PMD) on Tuesday reported a loss of $500,000 in its third quarter. On a per-share basis, the Dallas-based company said it had a loss of 9 cents.

Article Link